These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23657438)

  • 1. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
    Felger JC; Mun J; Kimmel HL; Nye JA; Drake DF; Hernandez CR; Freeman AA; Rye DB; Goodman MM; Howell LL; Miller AH
    Neuropsychopharmacology; 2013 Oct; 38(11):2179-87. PubMed ID: 23657438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.
    Narendran R; Jedema HP; Lopresti BJ; Mason NS; Gurnsey K; Ruszkiewicz J; Chen CM; Deuitch L; Frankle WG; Bradberry CW
    Mol Psychiatry; 2014 Mar; 19(3):302-10. PubMed ID: 23439486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa reverses cytokine-induced reductions in striatal dopamine release.
    Felger JC; Hernandez CR; Miller AH
    Int J Neuropsychopharmacol; 2015 Jan; 18(4):. PubMed ID: 25638816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
    Breier A; Su TP; Saunders R; Carson RE; Kolachana BS; de Bartolomeis A; Weinberger DR; Weisenfeld N; Malhotra AK; Eckelman WC; Pickar D
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2569-74. PubMed ID: 9122236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raclopride studies of dopamine release: dependence on presynaptic integrity.
    Doudet DJ; Holden JE
    Biol Psychiatry; 2003 Dec; 54(11):1193-9. PubMed ID: 14643086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
    Gallezot JD; Kloczynski T; Weinzimmer D; Labaree D; Zheng MQ; Lim K; Rabiner EA; Ridler K; Pittman B; Huang Y; Carson RE; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2014 Mar; 39(4):866-74. PubMed ID: 24220025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
    Gifford AN; Park MH; Kash TL; Herman LM; Park EH; Gatley SJ; Volkow ND
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):413-8. PubMed ID: 11111836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
    Thompson JL; Rosell DR; Slifstein M; Xu X; Rothstein EG; Modiano YA; Kegeles LS; Koenigsberg HW; New AS; Hazlett EA; McClure MM; Perez-Rodriguez MM; Siever LJ; Abi-Dargham A
    Psychopharmacology (Berl); 2020 Sep; 237(9):2649-2659. PubMed ID: 32572588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of striatal dopamine D2 receptors in nonhuman primates: increases in availability produced by chronic raclopride treatment.
    Czoty PW; Gage HD; Nader MA
    Synapse; 2005 Dec; 58(4):215-9. PubMed ID: 16206180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased dopamine activity predicts relapse in methamphetamine abusers.
    Wang GJ; Smith L; Volkow ND; Telang F; Logan J; Tomasi D; Wong CT; Hoffman W; Jayne M; Alia-Klein N; Thanos P; Fowler JS
    Mol Psychiatry; 2012 Sep; 17(9):918-25. PubMed ID: 21747399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings.
    Marcellino D; Kehr J; Agnati LF; Fuxe K
    Synapse; 2012 Mar; 66(3):196-203. PubMed ID: 22034017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-induced dopamine release in rat: Whole-brain spatiotemporal analysis with [
    Johansson J; Ericsson M; Axelsson J; Bjerkén SA; Virel A; Karalija N
    J Cereb Blood Flow Metab; 2024 Mar; 44(3):434-445. PubMed ID: 37882727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.